My only take on the article and lack of Amarantus being mentioned (not surprising) is that Lympro, when announced, will come out of left field to surprise many and hopefully make a much bigger splash when people start asking how in the hell did they not know about it. Hopefully it will cause a lot of journalist to clamor to interview Gerald.
But again, we all will have to wait and see as all is silent at Amarantus' front.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.